Tern Therapeutics

Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.

Company Details

Founded: 2023
Employees: Between 2 - 10 employees
Raised: $15,000,000
Public: No
Acquired: No
CEO: Alex M. Bailey, Ph.D.
Founders: Christina M. Ohnsman
Alex M. Bailey, Ph.D.
Matthew Rosini

Company Collections

These are collections Tern Therapeutics is a part of. Click on the collection name to view similar companies.

Tern Therapeutics' Industries

Medical Organizations

Biotechnology Companies

Total Amount Raised: $15,000,000

Tern Therapeutics Funding Rounds

Seed
$15,000,000
Aug 26, 2024
Seed Investors
ATW Partners
Steve Oliveira

Funding info provided by Diffbot.

Tern Therapeutics Reviews

Based on 0 reviews

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Tern Therapeutics.